Landscapes / Companies
Beam Therapeutics Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
4 in Phase 2
1 in Phase 1
Drugs
5
in active trials
Trials
5 active
5 since 2021
Drugs5
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | Dec 2026Phase 1/2 trial completes | |||
| Next date | Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 30 Dec 2027Phase 1/2 trial completes | |||
| Next date | 30 Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Glycogen Storage Disease Type Ia | ||||
| Open drug page | |||||
— |
Phase 1/2 | Feb 2028Phase 1/2 trial completes | |||
| Next date | Feb 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Sickle Cell Disease | ||||
| Open drug page | |||||
— |
Phase 1/2 | May 2028Phase 1/2 trial completes | |||
| Next date | May 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Alpha 1-Antitrypsin Deficiency | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021